Scynexis INC Schedule 13G passive stakes

SCYNEXIS, Inc. has filed a Schedule 13G amendment detailing beneficial ownership changes by CVI Investments, Inc. and Heights Capital Management, Inc.

Great Point Partners, LLC, along with Dr. Jeffrey R. Jay, M.D. and Ms. Lillian Nordahl, has reported a beneficial ownership of 9.99% in SCYNEXIS, Inc. common stock as of June 30, 2026.

Adage Capital Management, L.P. and its affiliates have reported beneficial ownership of 9.99% of SCYNEXIS, Inc.'s common stock, including shares issuable upon warrant exercise.

Federated Hermes, Inc. and related entities report a 4.03% beneficial ownership stake in SCYNEXIS Inc. as of June 30, 2026.

Federated Hermes, Inc. and associated entities report a 4.45% beneficial ownership stake in SCYNEXIS Inc. common stock as of June 30, 2026.

CVI Investments, Inc. and Heights Capital Management, Inc. report a combined 6.2% stake in SCYNEXIS, Inc. as of March 31, 2026.

CVI Investments, Inc. and Heights Capital Management, Inc. report combined beneficial ownership of 6.7% of SCYNEXIS, Inc. common stock.

Squadron Master Fund LP, along with its affiliates, has disclosed beneficial ownership of 7,608,695 shares, representing 9.6% of Scynexis Inc.'s common stock.

Great Point Partners, LLC, along with Dr. Jeffrey R. Jay, M.D. and Ms. Lillian Nordahl, has reported beneficial ownership of 9.99% of Scynexis, Inc.'s common stock as of March 31, 2026.

Avidity Partners Management LP and related entities have filed an amended Schedule 13G, disclosing a 9.9% beneficial ownership stake in Scynexis, Inc. as of December 31, 2025.

Kingdon Capital Management and Mark Kingdon have reported a complete divestment of their beneficial ownership in SCYNEXIS INC, reducing their stake to 0%.

Federated Hermes, Inc. and affiliated entities have disclosed a beneficial ownership of 8.42% of SCYNEXIS, INC. common stock as of December 31, 2025.

Avidity Partners and related entities have filed an Amendment No. 7 to their Schedule 13G, disclosing a 9.9% beneficial ownership stake in Scynexis, Inc. as of September 30, 2025.

Kingdon Capital Management and Mark Kingdon report a 5.3% beneficial ownership in SCYNEXIS INC, while M. Kingdon Offshore Master Fund and Kingdon GP exit their positions below 5%.

Federated Hermes, Inc. and related entities have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 11.26% in SCYNEXIS INC common stock.

Avidity Partners and its affiliated funds, along with key individuals, have filed an amended Schedule 13G, reporting a collective 9.9% beneficial ownership in SCYNEXIS INC as of December 31, 2024.

Federated Hermes, Inc. and related entities have filed an Amendment No. 14 to their Schedule 13G, reaffirming their beneficial ownership of 15.50% of SCYNEXIS, INC. common stock as of December 31, 2024, held in the ordinary course of business.